Machine Learning: Diagnostic of Prostate Cancer Status

Revolutionizing Prostate Cancer Screening With AI-Driven Diagnostic Advancements

Our client’s requirement

A Biotech firm based on the US East Coast connected with Excelra to help revolutionize prostate cancer screening. The objective was to enhance the reliability of screening, reducing unnecessary biopsies and associated risks, such as bleeding, infection, and additional healthcare costs.

Our approach

We implemented AI/ML techniques leveraging a new semen sample analysis containing diverse biomarkers. Utilized ensemble learning methodologies including Deep Neural Networks and Gradient Boosted Decision Trees.